MARY WRIGHT: Open Payments
NPI 1679188767 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 16 payments from 10 companies in 2025. Trend: 2023 $112 · 2024 $679 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 2 | $178 |
| Medtronic, Inc. | 4 | $158 |
| BETA BIONICS, INC. | 2 | $39 |
| Lilly USA, LLC | 2 | $33 |
| Hollister Incorporated | 1 | $33 |
| Novo Nordisk Inc | 1 | $25 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| TOLMAR, INC. | 1 | $21 |
| Ascendis Pharma Endocrinology Inc | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
Products named: Omnipod, MINIMED 780G, iLet Bionic Pancreas, MOUNJARO, New Image, Ozempic, JATENZO, Yorvipath.
Industry payments across VA — which companies pay providers there.
